Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identification of the major pathogenic Candida species

Journal of Medical Microbiology

Volumn 56, Issue 4, 2007, Pages 495-499

  Sendid, Boualem ^a,b   François, Nadine ^b   Standaert, Annie ^a   Dehecq, Eric ^c   Zerimech, Farid ^b   Camus, Daniel ^b   Poulain, Daniel ^a,b  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Centre Hospitalier Saint Philibert GHICL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; COMPARATIVE STUDY; CULTURE MEDIUM; EVALUATION; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; NONHUMAN; PRIORITY JOURNAL; YEAST;

CANDIDA; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; HUMANS; MYCOSES; SPECIES SPECIFICITY;

EID: 34247210213     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46715-0     Document Type: Article

References (17)

1. Buchner, T., Fegeler, W., Bernhardt, H., Brockmeyer, N., Duswald, K. H., Herrmann, M., Heuser, D., Jehn, U., Just-Nubling, G. & other authors (2002). Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators. Eur J Clin Microbiol Infect Dis 21, 337-352.
2. Cardenes, C. D., Carrillo, A. J., Arias, A., Rodriguez-Alvarez, C., Torres-Lana, A., Sierra, A. & Arevalo, M. P. (2002). Comparison of Albicans ID2 agar plate with the germ tube for presumptive identification of Candida albicans. Diagn Microbiol Infect Dis 42, 181-185.
3. Cooke, V. M., Miles, R. J., Price, R. G., Midgley, G., Khamri, W. & Richardson, A. C. (2002). New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 68, 3622-3627.
4. Eggimann, P., Garbino, J. & Pittet, D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3, 685-702.
5. Fricker-Hidalgo, H., Orenga, S., Lebeau, B., Pelloux, H., Brenier-Pinchart, M. P., Ambroise-Thomas, P. & Grillot, R. (2001). Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species. J Clin Microbiol 39, 1647-1649.
6. Letscher-Bru, V., Meyer, M. H., Galoisy, A. C., Waller, J. & Candolfi, E. (2002). Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species. J Clin Microbiol 40, 1508-1510.
7. Marr, K. A. (2004). Invasive Candida infections: the changing epidemiology. Oncology (Williston Park) 18, 9-14.
8. Nucci, M. & Marr, K. A. (2005). Emerging fungal diseases. Clin Infect Dis 41, 521-526.
9. Odds, F. C. & Bernaerts, R. (1994). CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32, 1923-1929.
10. Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J. & Edwards, J. E. (2004). Guidelines for treatment of candidiasis. Clin Infect Dis 38, 161-189.
11. Pasqualotto, A. C., Nedel, W. L., Machado, T. S. & Severo, L. C. (2005). A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia. J Hosp Infect 60, 129-134.
12. Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E. & Edwards, J. E. (2000). Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 30, 662-678.
13. Richardson, M. D. (2005). Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56 (Suppl. 1), i5-i11.
14. Rousselle, P., Freydiere, A. M., Couillerot, P. J., de Montclos, H. & Gille, Y. (1994). Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates. J Clin Microbiol 32, 3034-3036.
15. Sanglard, D. & Odds, F. C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73-85.
16. Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E. & Anaissie, E. (2004). Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10 (Suppl. 1), 48-66.
17. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. & Edmond, M. B. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317.